BETTER THERAPEUTICS INC (BTTX)

US08773T1043 - Common Stock

0.0446  +0.01 (+27.43%)

After market: 0.036 -0.01 (-19.28%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.00
Operating Expenses
29.62M38.26M30.56M0.00
Research and Development
10.51M16.44M19.44MN/A
Selling, General, and Administrative Expenses
19.11M21.82M11.12MN/A
Operating Income
-29.62M-38.26M-30.56M0.00
Interest Income/Expense
-1.95M-1.49M-190.00KN/A
Non Recurring Items
N/A0.00-9.74MN/A
Income Before Taxes
-31.57M-39.75M-40.49M0.00
Income Tax
3.00K10.00K-150.00KN/A
Net Income
-31.58M-39.76M-40.34M0.00
EBITDA
-26.51M-35.53M-28.94MN/A
 
Per Share Data
EPS Diluted Total Ops
-1.15-1.69-1.710.00
Non GAAP EPS
-1.15-1.68N/AN/A
 
Statistics

All data in USD

Charts